Pittsburgh -Topical tacrolimus ointment 0.1 percent (Protopic) may be a viable addition to the current therapeutic armamentarium for early-stage cutaneous T-cell lymphoma (CTCL), Larisa Geskin, M.D., said.
DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
85% of Survey Respondents Do Not Know What Actinic Keratosis Is
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Understanding the Impact of Prurigo Nodularis Itch, Sleep Loss, and Quality of Life
2023 Dermatology Research to Ponder